The current wave of COVID-19 highlights a particularly high risk of reinfection by the Omicron variant of SARS-CoV-2. Why is this? A team from the Centre for Emerging Viral Diseases of the University of Geneva (UNIGE) and of the Geneva University Hospital (HUG) analysed the antibody neutralisation capacity of 120 people infected with the original SARS-CoV-2 strain, or with one of its Alpha, Beta, Gamma, Delta, Zeta or Omicron (sub-variant BA.1) variants.
- Study could help better management of Alzheimer’s patients
admin Tue, 07/05/2022 - 15:50
A team of researchers at the Bengaluru-based Indian Institute of Science (IISc) has developed a GPU-based machine learning algorithm that promises to help identify early signs of aging or deterioration of brain function before they manifest behaviourally in Alzheimers patients.
- Time to move from Volume to Value leadership to capture global market, Says Health Minister
admin Mon, 07/04/2022 - 16:10
Let us move from Volume to Value leadership to capture global pharmaceutical market. It is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop our own models focused on accelerating production to meet the domestic demand while increasing our global footprint. Union Minister for Chemicals & Fertilizers and Health & Family Welfare, Dr. Mansukh Mandaviya exhorted the champions and leaders of Pharmaceutical Industry at the interactive session with Indian Pharmaceutical Alliance.
- 9th edition of Indian Pharmacopoeia is released by IPC
admin Mon, 07/04/2022 - 16:05
Union Minister for Health and Family Welfare and Chemicals and Fertilisers, Dr. Mansukh Mandaviya chaired IPC Conference 2022 and released 9th edition of Indian Pharmacopoeia on 1st July at Vigyan Bhawan, New Delhi.
- NIPER SAS Nagar student gets Rs. 27.8 lakh annual package
admin Fri, 07/01/2022 - 16:25
NIPER SAS Nagar has informed that the highest annual package offered to a student is Rs. 27.8 lakh. Many companies conducted campus interviews for the M.Pharm or Masters students of the batch 2020-22.
- Dr Reddys Laboratories has settled patent litigation with Indivior Inc and Aquestive Therapeutics
admin Fri, 07/01/2022 - 16:19
Dr Reddys Laboratories has settled patent litigation with Indivior Inc and Aquestive Therapeutics on a medication used to treat opioid dependence or addiction. A US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.
- Novartis starts new manufacturing plant in Mumbai
admin Fri, 07/01/2022 - 16:13
Novartis starts a new plant in Mumbai to make generic cancer drugs. It said that to reinforce our commitment to improving and extending people’s lives, Sandoz Technical Operations, a Novartis division, inaugurated its manufacturing plant for medicines and therapies at Kalwe in Mumbai today.
The plant, which marks a new chapter for Sandoz, will further strengthen the company’s operations in India to support growing healthcare needs globally.
- Higher Protein Intake While Dieting Leads to Healthier Eating
admin Tue, 06/28/2022 - 15:42
Eating a larger proportion of protein while dieting leads to better food choices and helps avoid the loss of lean body mass, according to a Rutgers study.
An analysis of pooled data from multiple weight-loss trials conducted at Rutgers shows that increasing the amount of protein even slightly, from 18 percent of a person’s food intake to 20 percent, has a substantial impact on the quality of the food choices made by the person. The study was published in the medical journal Obesity.
- Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease ; study finds
admin Tue, 06/28/2022 - 15:32
A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of three anti-spike neutralizing monoclonal antibodies for mild to moderate symptoms led to low rates of severe disease, hospitalization, ICU admission and mortality, according to Mayo Clinic researchers.